GSK Files Motion to Dismiss Zofran Birth Defect Claims
Attorneys for GlaxoSmithKline (GSK) have petitioned that Zofran lawsuits involving birth defects filed against the company be dismissed by the federal judge overseeing litigation. The move comes relatively early in the course of a multidistrict litigation (MDL 2657) set up to process the increasing number of lawsuits filed over birth defects... Read more »